Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUARDS: Ursodeoxycholic Acid in Gestational Diabetes
NCT06127355Phase 3Completed
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- Mar 2021
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ursodeoxycholic acid in gestational diabetes mellitus (GDM), sponsored by Fundación para la Formación e Investigación Sanitaria. Started Mar 2021; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT06127355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06127355.